SmallCapIntel Stock Signal

$GELS

GELS

Live signal history, momentum scoring, market alert activity, and recent catalysts.

Latest Signal

Active Watch

Grade

Grade C

Score

64/100

Speculative Confidence

Change

+47.98%

Previous Volume

6.2M

Signal Strength

Speculative Watch

64%

LowSpeculativeHighExtreme

Intelligence Summary

Why this signal matters

GELS triggered a C-rated Active Watch after moving +47.98%. The stock is currently priced at $1.49, with prior-session volume of 6.2M. SmallCapIntel assigned a 64/100 score based on price momentum, liquidity quality, and trader-friendly price-zone behavior.

Signal Breakdown

Score Components

Momentum22/35
Liquidity18/25
Price Quality20/20
Bonus4/10
Penalties0
Total64/100

Recent Catalysts

News and market-moving context

3 items found

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Tumble Ahead Of SC Ruling On Trump's Tariffs— Wells Fargo, BP, WeRide In Focus (UPDATED)

Benzinga · 1/14/2026, 1:36:05 PM

Earnings / FinancialsMedium Strength

U.S. stock futures declined on Wednesday as investors await a Supreme Court ruling on Trump's tariff authority. The Consumer Price Index rose 2.7% year-over-year in December, matching expectations, while core CPI came in slightly below forecasts at 2.6%. Major indices including the Dow Jones, S&P 500, and Nasdaq 100 all declined in premarket trading. Notable movers include Wells Fargo reporting earnings, BP announcing a $5 billion writedown in energy transition businesses, WeRide launching a robotaxi service on WeChat, and TG Therapeutics providing optimistic 2026 guidance.

Gelteq Appoints Matthew Jones as Head of Sports Performance

GlobeNewswire Inc. · 1/24/2025, 1:00:00 PM

No Clear CatalystUnknown Strength

Gelteq Limited, a global biotechnology company, has appointed Matthew Jones as Head of Sports Performance to oversee the growth, outreach, and customer strategy of its sports vertical. Jones, a leading sports dietitian, will focus on expanding the adoption of Gelteq's gel-based delivery platform in the sports industry.

Gelteq Limited Closes US$5.2 Million Initial Public Offering

GlobeNewswire Inc. · 10/30/2024, 2:00:00 PM

FinancingLow Strength

Gelteq Limited, a global biotechnology company, announced the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The company intends to use the net proceeds from the offering for various purposes, including funding certain manufacturing, marketing, and research and development activities.

Bull Case

Why traders may watch it

Healthy prior-session volume suggests tradable liquidity.
Price sits in a trader-friendly range where small-cap momentum can attract attention.
Momentum and liquidity conditions are aligned enough to earn a bonus score.

Risk Factors

What could go wrong

Small-cap momentum can reverse quickly.
High percentage moves often come with elevated volatility.
This is not investment advice and should be used for research only.

Signal History

1 total alert logged for $GELS.

View all alerts →

Active Watch

6/15/2026, 2:00:31 PM

Grade: CScore: 64/100+47.98%$1.49Prev Vol: 6.2M

Market data is informational only. Not investment advice.